Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?

MeSH terms

• Anticoagulants / therapeutic use
• Atrial Appendage* / physiopathology
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Humans
• Renal Insufficiency, Chronic* / complications
• Risk Factors
• Stroke / etiology
• Stroke / prevention & control
• Thromboembolism* / etiology
• Thromboembolism* / prevention & control
• Treatment Outcome